Dawnrays Pharmaceutical Holdings Ltd. had a revenue of 501.23M in the quarter ending Dec 31, 2023, with -22.88%. This bring the company's revenue in the last twelve months to 1.15B, Increased -11.73%. In the fiscal year ending Dec 31, 2023, Dawnrays Pharmaceutical Holdings Ltd. had annual revenue of 1.15B with -9.90% growth.